DISPENSING HIGH RISK/ALERT MEDICATIONS. Lana Gordineer, MSN, RN Diabetes Educator

Size: px
Start display at page:

Download "DISPENSING HIGH RISK/ALERT MEDICATIONS. Lana Gordineer, MSN, RN Diabetes Educator"

Transcription

1

2 DISPENSING HIGH RISK/ALERT MEDICATIONS Lana Gordineer, MSN, RN Diabetes Educator

3 HIGH RISK/ALERT MEDICATIONS (or DRUGS) Medications that have a high risk of causing serious injury or death to a patient if they are misused. Errors with these products are not necessarily more common but their results are more devastating. Examples of high-alert medications include heparin, warfarin, insulin, chemotherapy, concentrated electrolytes, opiate narcotics, neuromuscular blocking agents, thrombolytics, and adrenergic agonists. ISMP

4 HIGH RISK/ALERT MEDICATIONS How can we fine tune our organizational skills? Considering the following work related problems: -Interruptions -High patient acuity -Staffing -Change in assignment -Intimidation

5

6 HIGH RISK MEDICATIONS What steps can we take to eliminate medication errors?

7 High Risk Medications High Risk-High Alert Medications should be closely monitored. These drugs pose an increased risk of causing significant patient harm when used in error. ALWAYS GET YOUR HIGH RISK MEDICATION DOUBLE CHECKED AND COSIGNED.

8 HIGH RISK MEDICATIONS Independent Double Check: A procedure in which two individuals, preferably two licensed practitioners, separately check each component of the work process. An example would be one person calculating a medication dose for a specific patient and a second individual independently performing the same calculation (not just verifying the calculation) and matching results.

9

10 HIGH RISK MEDICATIONS What are some of the ways we can highlight the high risk medications so they just jump out at you? TALL MAN labeling High Alert labeling

11 Preventing Medication Errors The Five Rights of Safe Medication Administration RIGHT DRUG (does it look right) RIGHT ROUTE RIGHT DOSE RIGHT TIME RIGHT PATIENT (use 2 identifiers) Right to refuse Right to know

12

13 Preventing Medication Errors Key Elements: Understand the entire medication system Take a cognitive and proactive approach to error

14 OOPS, SORRY WRONG PATIENT! Wrong patient errors, occur in a variety of ways and may originate during any phase of the medication use process, not just during drug administration.

15 DISPENSING HIGH RISK MEDICATIONS It is essential that the Nurse be aware of all the information regarding high risk medications and the potentially lethal results when these medications are given not using proper guidelines and recommendations.

16 DISPENSING HIGH RISK MEDICATIONS Bayhealth policy states: High alert medications are medications frequently implicated in medication errors, with the potential for significant adverse patient outcomes. To have in place guardrails/processes to prevent errors involving the interchange of sound alike/look alike medications. (policy B )

17 Medication Administration Procedure Research drugs that are unfamiliar to you using available references. Check each patient s MAR for drug dose, route and time before beginning patient care each shift. Know your patients status, what are their vital signs, are they NPO, etc. Bring patient s s MAR and medications into the room with you before opening the medications. Know the proper procedures to use when giving medications IV, oral, subcutaneous, rectal, and IM.

18 Medication Administration Procedure Medications that are verified (double checked) with another nurse before administration are: Insulin Heparin Parenteral Digitalis All calculations for fractional dosages

19 Adverse Drug Reactions Any unintended and/or unexpected response to a medication which causes or prolongs hospitalization and/or requires treatment with a prescription drug and/or is fatal or life-threatening. threatening. Report Report all reactions or suspected ADRs to the Adverse Drug Reaction Hotline: (KGH ; MMH ).

20 Adverse Drug Reactions ADRs-is a subset of ADEs that includes any clinical manifestation that is undesired, unintended, or unexpected that is consequent to and caused by the administration of medications or IV fluids. American Hospital Association, Health Research & Educational Trust, and the Institute for Safe Medication Practices

21 List of High Risk Medications The list is actually very long but we are going to concentrate on the following groups of High Risk Medications: Anticoagulants Insulins Electrolytes Opiates Chemotherapeutic Agents Adrenergic agonists, IV (e.g., epinephrine)

22 ANTICOAGULANTS Prevent blood clot formation by interfering with different factors in the thrombosis formation cascade causing increased bleeding times. Require ongoing lab monitoring. Medications include: ASA, Heparin, Coumadin, Lovenox, Arixtra. Using more than one anticoagulant can increase the bleeding time, Check to see if using as a bridge therapy or if it was an oversight by the prescribing physician.

23 INSULINS Wide variety of insulins are available. Know the duration of each type of insulin, when it is to be administered, and if it is compatible with other types of insulins Hypoglycemia is the most common adverse reaction. Always look up a medication you are unfamiliar with-keep your patient safe.

24 ELECTROLYTES Electrolytes are the life energy of the cell and of life. Too much or too little can be severe and life-threatening. The sodium-potassium pump is a prime example of this. It is no wonder that electrolytes such as potassium, phosphate, and sodium chloride >0.9% are included with high risk medications.

25 OPIATES Narcotic agents that control or eliminate pain. When in excess will cause respiratory depression, often requiring a reversal agent. Patients are also at risk for fluid deficit due to N/V, falls, and anaphylactic reactions.

26 Chemotherapuetic Agents or Antineoplastic Agents Treatment of choice for malignancies of the hematopoietic system and for solid tumors, including solid tumors that have metastasized regionally or distally. Chemotherapeutic agents are mutagenic, teratogenic or carcinogenic. They can cause localized skin irritation or damage. They are considered hazardous. Healthcare workers should take precautions to avoid direct contact.

27 ADRENERGIC AGONISTS (e.g., epinephrine) Results in relaxation of cardiac and bronchial smooth muscle and dilation of skeletal muscle vessels. Available in different concentrations (e.g., 1:1000, 1:10,000). In emergencies often are drawn up into unlabeled syringes or put in unlabeled or incorrectly labeled cups or pans.

28 JCAHO 2007 National Patient Safety Goals Goal 1 Improve the accuracy of patient identification Goal 2 Improve the effectiveness of communication among care givers Goal 3 Improve the safety of using medications Goal 7 Reduce the risk of health care-associated infections Goal 8 Accurately & completely reconcile medications across the continuum of care Goal 9 Reduce the risk of patient harm resulting from falls Goal 13 Encourage patients active involvement in their own care as a patient safety strategy Goal 15 The organization identifies safety risks inherent in its patient population

29 What can happen when the rules are not followed. Reports from the Institute of Safe Medication Practice (ISMP). Chemotherapeutics Insulin Narcotics Electrolytes Anticoagulants Adrenerics

30 Worse Practice Using unapproved abbreviations Rushing (not using a double check) Not knowing the facts about the medications you are dispensing Not following the 5 Rights of Safe Medication Practice Failing to initiate the medication reconciliation form Failing to question or investigate when your RED flag pops up. Failing to follow Bayhealth policies

31 Best Practice Use only approved abbreviations Always get high risk medications double checked Initiate Medication Reconciliation form Follow the 5 Rights of Safe Medication Administration Research all medications you are dispensing If your RED flag pops up :question and/or investigate Always follow Bayhealth policies- you can t t go wrong

32 DISPENSING HIGH RISK MEDICATIONS ANY QUESTIONS?

Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins)

Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins) Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins) I HEAR YA KNOCKING BUT YOU CAN T COME IN (electrolytes) TAKE MY BREATH AWAY (Opiates-morphine) OUT WITH

More information

An introduction to High Risk Medications

An introduction to High Risk Medications An introduction to High Risk Medications Une politique sure des médicaments : déjà deux approches 25 octobre 2013 Danguy Christine Hôpital A. Vésale An introduction to High Risk Medications 1. High Risk

More information

Medication Management (Safe Practices 14-18)

Medication Management (Safe Practices 14-18) Medication Management (Safe Practices 14-18) David Bates, MD Hayley Burgess, PharmD Charles Denham, MD November 8, 2007 This Webinar focuses upon the following NQF-EndorsedTM Safe Practices: Safe Practice

More information

MEDICATION MANUAL Policy & Procedure

MEDICATION MANUAL Policy & Procedure MEDICATION MANUAL Policy & Procedure TITLE: High Alert Medication NUMBER: MM 50-010 Effective Date: September 13, 2013 Page 1 of 6 Applies To: Holders of Medication Manual This policy is applicable to

More information

Medications or therapeutic solutions may be injected directly into the bloodstream

Medications or therapeutic solutions may be injected directly into the bloodstream Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals

More information

MA 2000 Pharmacology for Medical Assistants

MA 2000 Pharmacology for Medical Assistants South Central College MA 2000 Pharmacology for Medical Assistants Course Information Description Total Credits 3.00 Total Hours 64.00 Types of Instruction In this course students will learn topics essential

More information

Administrative Policies and Procedures for MOH hospitals /PHC Centers. TITLE: Organization & Management Of Medication Use APPLIES TO: Hospital-wide

Administrative Policies and Procedures for MOH hospitals /PHC Centers. TITLE: Organization & Management Of Medication Use APPLIES TO: Hospital-wide Administrative Policies and Procedures for MOH hospitals /PHC Centers TITLE: Organization & Management Of Medication Use APPLIES TO: Hospital-wide NO. OF PAGES: ORIGINAL DATE: REVISION DATE : السیاسات

More information

The Massachusetts Coalition for the Prevention of Medical Errors. MHA Best Practice Recommendations to Reduce Medication Errors

The Massachusetts Coalition for the Prevention of Medical Errors. MHA Best Practice Recommendations to Reduce Medication Errors The Massachusetts Coalition for the Prevention of Medical Errors MHA Best Practice Recommendations to Reduce Medication Errors Executive Summary In 1997, the Massachusetts Coalition for the Prevention

More information

Objective. Failure Modes & Effects Analysis: A U-500 Insulin Case Study. What is a FMEA? Assembling a Team. Steps to Conducting a FMEA 5/12/2011

Objective. Failure Modes & Effects Analysis: A U-500 Insulin Case Study. What is a FMEA? Assembling a Team. Steps to Conducting a FMEA 5/12/2011 5/12/2011 Objective Failure Modes & Effects Analysis: A U-500 Insulin Case Study Understand the role of a failure mode and effects analysis (FMEA) in developing U-500 insulin use criteria Ryan J. Bickel,

More information

Reporting Adverse Events and Concerns at Stroger Hospital

Reporting Adverse Events and Concerns at Stroger Hospital Reporting Adverse Events and Concerns at Stroger Hospital Case Pt on coumadin comes in for community acquired pneumonia and is started on levaquin After several days, you note a lot of bruising.. You realize

More information

Roles and Responsibilities Policy

Roles and Responsibilities Policy Roles and Responsibilities Policy Contents Policy... 2 Scope/Audience... 2 Associated Documents... 2 Definitions... 2 Accountability... 2 Scope of Practice Statement:... 2 Anaesthetic Technicians... 3

More information

D( desired ) Q( quantity) X ( amount ) H( have)

D( desired ) Q( quantity) X ( amount ) H( have) Name: 3 (Pickar) Drug Dosage Calculations Chapter 10: Oral Dosage of Drugs Example 1 The physician orders Lasix 40 mg p.o. daily. You have Lasix in 20 mg, 40 mg, and 80 mg tablets. If you use the 20 mg

More information

Upstate University Health System Medication Exam - Version A

Upstate University Health System Medication Exam - Version A Upstate University Health System Medication Exam - Version A Name: ID Number: Date: Unit: Directions: Please read each question below. Choose the best response for each of the Multiple Choice and Medication

More information

Office of Clinical Standards and Quality / Survey & Certification Group

Office of Clinical Standards and Quality / Survey & Certification Group DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C2-21-16 Baltimore, Maryland 21244-1850 Office of Clinical Standards and Quality / Survey

More information

National Patient Safety Goals Effective January 1, 2015

National Patient Safety Goals Effective January 1, 2015 National Patient Safety Goals Goal 1 Nursing are enter ccreditation Program Improve the accuracy of patient and resident identification. NPSG.01.01.01 Use at least two patient or resident identifiers when

More information

ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS

ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS SASKATOON DISTRICT HEALTH Department of Nursing Affairs ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS SPECIAL NURSING PROCEDURE LEARNING PACKAGE This package provides the basic information necessary

More information

Insulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN

Insulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN Insulin: A Practice Update Department of Nursing Staff Development Elizabeth Borgelt, MS, RN Learning Outcome The learner will be able to identify the different types of insulins available, their actions,

More information

Administering Medications

Administering Medications Administering Medications Pharmacology for Healthcare Professionals seventh edition Donna F. Gauwitz, R.N., Nursing Consultant Senior Teaching Specialist of Nursing University of Minnesota Minnesota and

More information

Chapter 15. Reconstitution and Dosages Measured in Units. Copyright 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved.

Chapter 15. Reconstitution and Dosages Measured in Units. Copyright 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved. Chapter 15 Reconstitution and Dosages Measured in Units 1 Objectives Calculating drug dosage problems that first require reconstitution of a powdered drug into a liquid form Using a proportion to solve

More information

V: Infusion Therapy. Alberta Licensed Practical Nurses Competency Profile 217

V: Infusion Therapy. Alberta Licensed Practical Nurses Competency Profile 217 V: Infusion Therapy Alberta Licensed Practical Nurses Competency Profile 217 Competency: V-1 Knowledge of Intravenous Therapy V-1-1 V-1-2 V-1-3 V-1-4 V-1-5 Demonstrate knowledge and ability to apply critical

More information

Adverse Drug Events and Medication Safety: Diabetes Agents and Hypoglycemia

Adverse Drug Events and Medication Safety: Diabetes Agents and Hypoglycemia Adverse Drug Events and Medication Safety: Diabetes Agents and Hypoglycemia Date: October 20, 2015 Presented by Mike Crooks, PharmD., PCMH-CCE Pharmacy Interventions, Technical Lead 11/9/2015 1 Objectives:

More information

National Patient Safety Goals Effective January 1, 2015

National Patient Safety Goals Effective January 1, 2015 National Patient Safety Goals Effective January 1, 2015 Goal 1 Improve the accuracy of resident identification. NPSG.01.01.01 Long Term are ccreditation Program Medicare/Medicaid ertification-based Option

More information

National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment

National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient

More information

SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions

SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions SECTION N: MEDICATIONS Intent: The intent of the items in this section is to record the number of days, during the last 7 days (or since admission/reentry if less than 7 days) that any type of injection,

More information

Reducing the risk of patient harm: A focus on insulin

Reducing the risk of patient harm: A focus on insulin Reducing the risk of patient harm: A focus on insulin New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 1 Disclosure Matt Fricker, Matt Grissinger,

More information

Humulin R (U500) insulin: Prescribing Guidance

Humulin R (U500) insulin: Prescribing Guidance Leeds Humulin R (U500) insulin: Prescribing Guidance Amber Drug Level 2 We have started your patient on Humulin R (U500) insulin for the treatment of diabetic patients with marked insulin resistance requiring

More information

PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults

PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults PROTOCOL NUMBER: 7 PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults THIS PROTOCOL APPLIES TO: UW Health Clinics: all adult outpatients with an active order for warfarin TARGET

More information

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HIGH RISK MEDICATIONS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED

More information

Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)

Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3) Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3) List the different medication effects (p5) List the ways that medications

More information

PPP 1. Continuation of a medication to ensure continuity of care

PPP 1. Continuation of a medication to ensure continuity of care PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The

More information

Medical/Clinical Assistant CIP 51.0801 Task Grid

Medical/Clinical Assistant CIP 51.0801 Task Grid 1 Secondary Task List 100 PHARMACOLOGY 101 Measure drug dosages using droppers, medicine cups, syringes, and other specialized devices. 102 Utilize correct technique to administer medications using the

More information

Safe Handling of Hazardous Drugs

Safe Handling of Hazardous Drugs Safe Handling of Hazardous Drugs Staff Education May 1, 2015 Safe Handling of Hazardous Drugs Most hospitals have policies & procedures for the handling of cytotoxic drugs (chemotherapy) But what about

More information

Medication Guidelines

Medication Guidelines Medication Guidelines January 2014 Approved by the College and Association of Registered Nurses of Alberta Provincial Council, January 2014. Second printing with editorial change (p16), November 2014.

More information

ADMINISTRATION OF DRUG PRODUCTS/MEDICATIONS TO STUDENTS

ADMINISTRATION OF DRUG PRODUCTS/MEDICATIONS TO STUDENTS ADMINISTRATION OF DRUG PRODUCTS/MEDICATIONS TO STUDENTS 453.4 Drug products/medications are given to students in the school setting to continue or maintain a medical therapy which promotes health, prevents

More information

The nurse s role in dispensing, compounding and administering medications in British Columbia

The nurse s role in dispensing, compounding and administering medications in British Columbia Medications The nurse s role in dispensing, compounding and administering medications in British Columbia Please note that the information on dispensing on page 10 of this document is out of date. Refer

More information

SafetyFirst Alert. Errors in Transcribing and Administering Medications

SafetyFirst Alert. Errors in Transcribing and Administering Medications SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2001 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical

More information

Overview of emar Electronic Medication Administration Record

Overview of emar Electronic Medication Administration Record Overview of emar Electronic Medication Administration Record March 2006 WHAT IS emar? emar Electronic Medication Administration Record - Replaces the paper MAR MAK Medication Administration Check (Siemens)

More information

Epinephrine Administration Training for Unlicensed School Personnel

Epinephrine Administration Training for Unlicensed School Personnel Epinephrine Administration Training for Unlicensed School Personnel Management of Life-Threatening Allergies in the School Setting Dover and Sherborn Schools EpiPen Administration This program is designed

More information

UW School of Dentistry Comprehensive Medication Policy

UW School of Dentistry Comprehensive Medication Policy UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides

More information

Supplementary material: The online version of this article (doi: 10.1310/hpj5004-287) contains the eappendix.

Supplementary material: The online version of this article (doi: 10.1310/hpj5004-287) contains the eappendix. Hosp Pharm 2015;50(4):287 295 2015 Thomas Land Publishers, Inc. www.hospital-pharmacy.com doi: 10.1310/hpj5004-287 Original Article Nursing, Pharmacy, and Prescriber Knowledge and Perceptions of High-Alert

More information

Medication Administration for CNAs

Medication Administration for CNAs Medication Administration for CNAs Two (2.0) contact hours Expiration Date: 12/4/2017 First Published: 12/4/2013 Reproduction and distribution of these materials is prohibited without RN.com content licensing

More information

Electronic Medication Administration Record (emar) (For Cerner Sites Only)

Electronic Medication Administration Record (emar) (For Cerner Sites Only) POLICY NO. 1009 Approved: 12/05 Effective: 12/05 Reviewed: 9/10; 5/12 1. Purpose: Electronic Medication Administration Record (emar) (For Cerner Sites Only) To provide direction for the transcription and

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: infusion_therapy_in_the_home 3/1998 2/2016 2/2017 2/2016 Description of Procedure or Service Home infusion

More information

Revised: X Date: 04/07/14. 1. All medication orders shall be reviewed, signed, or co-signed by a Registered Nurse (RN).

Revised: X Date: 04/07/14. 1. All medication orders shall be reviewed, signed, or co-signed by a Registered Nurse (RN). Vermont Psychiatric Care Hospital Procedure Revised: X Date: 04/07/14 I. Medication Orders 1. All medication orders shall be reviewed, signed, or co-signed by a Registered Nurse (RN). 2. Medication orders

More information

CENTRAL IOWA HEALTHCARE Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE

CENTRAL IOWA HEALTHCARE Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE CENTRAL IOWA HEALTHCARE Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE Policy #: MM.01.01.03 Subject: High Alert and Hazardous Medications (including pharmaceutical waste management) Purpose: The hospital

More information

Objectives At the completion of this module, unlicensed assistive personnel (UAP) should be able to:

Objectives At the completion of this module, unlicensed assistive personnel (UAP) should be able to: Objectives At the completion of this module, unlicensed assistive personnel (UAP) should be able to: 1. administer medications by subcutaneous injections. 2. document medication administration in the client

More information

SAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy # 110.160.010

SAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy # 110.160.010 SAFE HANDLING OF HAZARDOUS MEDICATIONS Cytotoxic and Non-Cytotoxic Winnipeg Regional Health Authority Policy # 110.160.010 By the end of this presentation staff should be able to 1. Understand what information

More information

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013. Anticoagulants

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013. Anticoagulants MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013 Anticoagulants Anticoagulants are agents that prevent the formation of blood clots. Before we can talk about

More information

NHSG/PGD/lido_eton/MGPG412 Organisation Wide

NHSG/PGD/lido_eton/MGPG412 Organisation Wide Title: Patient Group Direction For The Administration Of Lidocaine 2% Injection For The Insertion/Removal Of The 68mg Etonogestrel Contraceptive Implant By Nurses And Midwives Working Within NHS Grampian

More information

Medication Reconciliation Training Packet. Legacy Health System

Medication Reconciliation Training Packet. Legacy Health System Medication Reconciliation Training Packet Legacy Health System 1 Objectives To identify the key elements of the medication reconciliation process To describe the role of the nurse in the medication reconciliation

More information

NCQAC RNs Working with Medical Assistants

NCQAC RNs Working with Medical Assistants 1 Working The Role of the Registered Nurse Nursing Care Quality Assurance Commission Nursing Practice Program 3 Objectives To provide an overview of the medical assistant categories and their scope of

More information

Unit/Standard Number. Proficiency Level Achieved: (X) Indicates Competency Achieved to Industry Proficiency Level

Unit/Standard Number. Proficiency Level Achieved: (X) Indicates Competency Achieved to Industry Proficiency Level 1 Secondary Task List 100 INTRODUCTION TO HEALTHCARE 101 Identify the roles and educational/credentialing requirements of various health care practitioners. 102 Describe the 's job description, personal

More information

What You Need to KnowWhen Taking Anticoagulation Medicine

What You Need to KnowWhen Taking Anticoagulation Medicine What You Need to KnowWhen Taking Anticoagulation Medicine What are anticoagulant medicines? Anticoagulant medicines are a group of medicines that inhibit blood clotting, helping to prevent blood clots.

More information

APPENDIX I-A: INFORMED CONSENT BB IND 11184 Protocol CDC IRB #4167

APPENDIX I-A: INFORMED CONSENT BB IND 11184 Protocol CDC IRB #4167 APPENDIX I-A: INFORMED CONSENT BB IND 11184 Protocol CDC IRB #4167 INFORMED CONSENT FOR USE OF DIPHTHERIA ANTITOXIN (DAT) FOR SUSPECTED DIPHTHERIA CASES Investigational New Drug (IND) BB 11184 Protocol

More information

Safe IV Compounding Procedures: The Release of ISMP Guidelines

Safe IV Compounding Procedures: The Release of ISMP Guidelines Safe IV Compounding Procedures: The Release of ISMP Guidelines Matthew P. Fricker, Jr., MS, RPh, FASHP, Program Director Institute for Safe Medication Practices 1 Objectives List system based causes of

More information

Recommended guidelines for. schools

Recommended guidelines for. schools Recommended guidelines for medication administration in schools Objective At the end of the session the nurses will be aware of the HAAD standards and roles and responsibilities of a nurse in medication

More information

ADMINISTRATION OF MEDICATION TO STUDENTS POLICY

ADMINISTRATION OF MEDICATION TO STUDENTS POLICY CODE: C.009 Program CONTENTS ADMINISTRATION OF MEDICATION TO STUDENTS 1.0 PRINCIPLES 2.0 POLICY FRAMEWORK 3.0 AUTHORIZATION POLICY 1.0 PRINCIPLES 1.1 The primary responsibility for administering medication

More information

SUBJECT: Final CRNP Regulations Pennsylvania State Board of Nursing

SUBJECT: Final CRNP Regulations Pennsylvania State Board of Nursing PACHC Memo 09-04 Applicable for: FQHC Management Team Human Resource Department Physicians Professional Nurses December 22, 2009 TO: Health Center CEOs FROM: Cheri Rinehart, President & CEO SUBJECT: Final

More information

A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO)

A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) Types of Catheter Related Thrombotic A catheter-related thrombus may be intraluminal (inside the catheter)

More information

GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION

GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION GUIDELINES GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION Preamble The purpose of this document is to provide guidance for the pharmacist

More information

NEW SECTION GENERAL [ 1 ] OTS-5292.5

NEW SECTION GENERAL [ 1 ] OTS-5292.5 WAC 246-827-0010 Definitions. The following definitions apply throughout this chapter unless the context clearly indicates otherwise: (1) "Direct visual supervision" means the supervising health care practitioner

More information

Parenteral Dosage of Drugs

Parenteral Dosage of Drugs Chapter 11 Parenteral Dosage of Drugs Parenteral Route of administration other than gastrointestinal Intramuscular (IM) Subcutaneous (SC) Intradermal (ID) IV Parenteral Most medications prepared in liquid

More information

Cytotoxic and Biotherapies Credentialing Programme Module 6

Cytotoxic and Biotherapies Credentialing Programme Module 6 Cytotoxic and Biotherapies Credentialing Programme Module 6 1. Safe Handling and Administration of Cytotoxic and Biotherapies 2. Waste and Spill Management At the completion of this module the RN will

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

Medical Assistants in Washington State: A Summary of Laws and Rules Effective July 1, 2013

Medical Assistants in Washington State: A Summary of Laws and Rules Effective July 1, 2013 Medical Assistants in Washington State: A Summary of Laws and Rules Effective July 1, 2013 Prepared by the WSMA Department of Legal Affairs For further information contact Denny Maher, JD, MD WSMA Director

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin PACKAGE LEAFLET: INFORMATION FOR THE USER VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution Cyanocobalamin Read all of this leaflet carefully before you start using this medicine because

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They

More information

CORONER S REPORT REPORT

CORONER S REPORT REPORT CORONER S REPORT 26 THE CORONER HAS RECOMMENDED THAT THE ONTARIO COLLEGE OF PHARMACISTS EDUCATE CLINICIANS ON THE DEFINITION OF OPIOID TOLERANCE, AND REVIEW THE PATIENT CONDITIONS AND COMORBIDITIES THAT

More information

Optimizing medication safety:

Optimizing medication safety: Optimizing medication safety: At King Abdullah Medical City advanced technologies help improve safety, security and control of N&C medications Authored and produced by CareFusion, June 2015 Summary At

More information

Medical Errors for CNAs & HHAs

Medical Errors for CNAs & HHAs Medical Errors for CNAs & HHAs Purpose: The purpose of this course is to provide CNAs and HHAs an overview of medical errors in today s health care system and what certified nurse s aides and home health

More information

National Quality Forum (NQF) Endorsed Set of 34 Safe Practices*

National Quality Forum (NQF) Endorsed Set of 34 Safe Practices* NQF Endorsed Set of Safe Practices (released 2009) 1. Leadership Structures and Systems Leadership structures and systems must be established to ensure that there is organization-wide awareness of patient

More information

Mississippi Board of Nursing

Mississippi Board of Nursing Mississippi Board of Nursing Regulating Nursing Practice www.msbn.state.ms.us 713 Pear Orchard Road, Suite 300 Ridgeland, MS 39157 Administration and Management of Intravenous (IV) Moderate Sedation POSITION

More information

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC Learning Objectives: 1. Identify the names and reasons/circumstances for additional toxicity of SELECTED OPIATES hydromorphone DILAUDID Methadone Fentanyl/DURAGESIC

More information

PHARMACY TECHNICIAN COURSE DESCRIPTIONS

PHARMACY TECHNICIAN COURSE DESCRIPTIONS PHARMACY TECHNICIAN COURSE DESCRIPTIONS OCCUPATIONAL COMPLETION POINTS AND PROGRAM LENGTH: * Basic Healthcare Worker OCP A 90 Hours (COURSE #HSC 0003) * Community Pharmacy Technician OCP B 360 Hours (COURSE

More information

RULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES

RULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES RULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES CHAPTER 0465-01-03 ADMINISTRATION OF MEDICATION BY UNLICENSED PERSONNEL TABLE OF CONTENTS 0465-01-03-.01 Purpose 0465-01-03-.06

More information

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HANDLING OF H AZARDOUS DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED

More information

2015 -- S 0169 S T A T E O F R H O D E I S L A N D

2015 -- S 0169 S T A T E O F R H O D E I S L A N D ======== LC000 ======== 01 -- S 01 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO INSURANCE - ACCIDENT AND SICKNESS INSURANCE POLICIES Introduced

More information

KILGORE COLLEGE ASSOCIATE DEGREE PROGRAM RNSG 1301 SYLLABUS PHARMACOLOGY. David Adamson, MSN, RN

KILGORE COLLEGE ASSOCIATE DEGREE PROGRAM RNSG 1301 SYLLABUS PHARMACOLOGY. David Adamson, MSN, RN KILGORE COLLEGE ASSOCIATE DEGREE PROGRAM RNSG 1301 SYLLABUS PHARMACOLOGY David Adamson, MSN, RN COURSE SYLLABUS RNSG 1301: Pharmacology RNSG 1301 Introduction in the science of pharmacology with emphasis

More information

N HUMAN Novo Nordisk Patient Information for Novolin N

N HUMAN Novo Nordisk Patient Information for Novolin N N HUMAN Novo Nordisk Patient Information for Novolin N NOVOLIN N (NO-voe-lin) NPH, Human Insulin Isophane Suspension Injection (recombinant DNA origin) 100 units/ml Important: Know your insulin. Do not

More information

RULES OF DEPARTMENT OF COMMUNITY HEALTH HEALTHCARE FACILITY REGULATION

RULES OF DEPARTMENT OF COMMUNITY HEALTH HEALTHCARE FACILITY REGULATION Disclaimer: This is an unofficial copy of the rules that has been provided for the convenience of the public by the Department of Community Health. The official rules for this program are on record with

More information

March 2015. Medication Guidelines

March 2015. Medication Guidelines March 2015 Medication Guidelines Approved by the College and Association of Registered Nurses of Alberta Provincial Council, March 2015. Permission to reproduce this document is granted. Please recognize

More information

Guide for general practice staff on reporting patient safety incidents to the National Reporting and Learning System

Guide for general practice staff on reporting patient safety incidents to the National Reporting and Learning System Guide for general practice staff on reporting patient safety incidents to the National Reporting and Learning System NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients

More information

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation

More information

OREGON HEALTH & SCIENCE UNIVERSITY SCOPE OF PRACTICE

OREGON HEALTH & SCIENCE UNIVERSITY SCOPE OF PRACTICE OREGON HEALTH & SCIENCE UNIVERSITY SCOPE OF PRACTICE Minimum Qualifications Task Clinical Dietician RN LPN MA/Tech BLS Certification Oversight Health Screening Requirements National registration as a RD

More information

Overview of the TJC/CMS VTE Core Measures

Overview of the TJC/CMS VTE Core Measures Overview of the TJC/CMS VTE Core Measures CMS Specification Manual 4.2 January 1, 2013 June 30, 2013 Victoria Agramonte, RN, MSN Project Manager, IPRO VTE Regional Learning Sessions NYS Partnership for

More information

Medication Safety: The Important Role of Pharmacy Technicians

Medication Safety: The Important Role of Pharmacy Technicians Medication Safety: The Important Role of Pharmacy Technicians CAPT - Alberta Pharmacy Technician Conference 2004 Sheraton Cavalier Hotel Calgary, Alberta September 11, 2004 David U President & CEO, ISMP

More information

Seven steps to patient safety The full reference guide. Second print August 2004

Seven steps to patient safety The full reference guide. Second print August 2004 Seven steps to patient safety The full reference guide Second print August 2004 National Patient Safety Agency Seven steps to patient safety 113 Appendix Four F Examples of events according to severity

More information

Center for Clinical Standards and Quality/Survey & Certification Group

Center for Clinical Standards and Quality/Survey & Certification Group DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C2-21-16 Baltimore, Maryland 21244-1850 Center for Clinical Standards and Quality/Survey

More information

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March 2007. Action for the NHS and the independent sector

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March 2007. Action for the NHS and the independent sector Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 4 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes

More information

The Joint Commission s Patient Safety Initiatives

The Joint Commission s Patient Safety Initiatives The Joint Commission s Patient Safety Initiatives Global Healthcare User Group (HUG) Princeton, November 30, 2005 Richard J. Croteau, M.D. Executive Director for Patient Safety Initiatives 1 The Joint

More information

Humulin (HU-mu-lin) R

Humulin (HU-mu-lin) R 1 PATIENT INFORMATION Humulin (HU-mu-lin) R Regular U-500 (Concentrated) insulin human injection, USP (rdna origin) Read the Patient Information that comes with Humulin R U-500 before you start taking

More information

Anticoagulant therapy

Anticoagulant therapy Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in

More information

Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip. A Review of the Research for Adults

Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip. A Review of the Research for Adults Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip A Review of the Research for Adults Is This Information Right for Me? Yes, if: You are considering or planning to

More information

University of Miami Clinical Enterprise Technologies

University of Miami Clinical Enterprise Technologies Nursing Manual Our Mission: To design and deliver ongoing support for a network of Business and Clinical Information Management Systems which enhance the academic and research vision while implementing

More information

FAQs about Warfarin (brand name Coumadin )

FAQs about Warfarin (brand name Coumadin ) FAQs about Warfarin (brand name Coumadin ) What is warfarin? Warfarin is the most commonly used anticoagulant in the US. An anticoagulant is a drug used to prevent unwanted and harmful blood clots. Although

More information

Risk Management Plan (RMP) Guidance (Draft)

Risk Management Plan (RMP) Guidance (Draft) Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour

More information

MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.

MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No. of 22 I. Purpose To establish safe medication practices for High Alert medications to maximize the safety of the medication processes associated with these medications. II. Policy. High alert medications

More information

CARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy

CARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy Page 1 of 5 INDICATIONS EXCLUSIONS 2 consecutive blood glucose measurements greater than 110 mg per dl AND NPO with a continuous caloric source AND Diagnosis of : Cardio-thoracic Surgery NOTE: This protocol

More information

The Importance of Using Insulin Safely. Learning Objectives

The Importance of Using Insulin Safely. Learning Objectives The Importance of Using Insulin Safely Victor Tran, PharmD PGY 1 Pharmacy Resident Ambulatory Care Diabetes Symposium November 12, 2015 Learning Objectives List the potential adverse drug events of insulin

More information